Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study
The British Journal of Radiology · 2023
DOI: 10.1259/bjr.20221195 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Radiology, 2023. Verfasst von Wu Hao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education /Beijing), Peking University Cancer Hosp…. Hauptthemen laut MEDLINE: Catheter Ablation, Liver Neoplasms, Radiofrequency Ablation, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To compare therapeutic efficacy between systemic chemotherapy (SC) alone and preoperative SC followed by radiofrequency ablation (SC+RFA) in patients with colorectal cancer liver metastases (CRLM).
Methods
This study identified a cohort of patients with CRLM after treatment between 2010 and 2016. Patients who received SC+RFA were compared with SC patients by propensity score matching. Overall survival (OS) and intrahepatic progression-free survival (PFS) were compared using stratified log-rank test. The outcomes after SC and SC+RFA were also assessed in patient subgroups.
Results
This study identified 338 patients with CRLM who had underwent SC and had different response to chemotherapy, including non-progressive disease (non-PD) or progressive disease (PD). Of this cohort, 64 patients in SC+RFA group were matched by propensity score to 64 patients who received SC alone. Compared with SC cohort, the SC+RFA cohort yielded better OS (HR, 0.403; 95% CI, 0.271–0.601) and PFS (HR, 0.190; 95% CI, 0.113–0.320). The estimated OS rates at 1, 3 and 5 years were 93.8%, 51.6% and 15.6% for SC+RFA group and 81.3%, 26.6% and 10.9% for SC group (p<0.001). The cumulative PFS rates at 1, 3, and 5 years were 43.8 %, 14.1% and 3.1% for the SC+RFA group and 1.6%, 0 and 0% for SC group (p<0.0001). In subgroup analysis, compared with patients with PD response, patients with non-PD response could gain better PFS (HR, 0.207; 95% CI, 0.121–0.354) and OS (HR, 0.390; 95% CI, 0.246–0.617).
Conclusions
RFA was associated with improved OS and intrahepatic PFS in CRLM patients with preoperative SC,especially in non-PD response subgroup after SC. Advances in knowledge: The addition of RFA was advocated for CRLM patients with preoperative SC. This study will provide important reference and evidence to better perform the management of unresectable CRLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ultrasound, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education /Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
- Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
- Department of Medical Oncology, People's Hospital of Zhengzhou, Zhengzhou, China.
Zitieren
APA
Hao, W., Jun, Z., Yan, L., Zhong-Yi, Z., Bin-Bin, J., Gui-Ju, L., Wei, Y., Lin, S., & Kun, Y. (2023). Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study. The British Journal of Radiology. https://doi.org/10.1259/bjr.20221195
Vancouver
Hao W, Jun Z, Yan L, Zhong-Yi Z, Bin-Bin J, Gui-Ju L, et al. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study. The British Journal of Radiology. 2023. doi:10.1259/bjr.20221195
BibTeX
@article{Hao2023,
author = {Hao, Wu and Jun, Zhou and Yan, Li and Zhong-Yi, Zhang and Bin-Bin, Jiang and Gui-Ju, Liu and Wei, Yang and Lin, Shen and Kun, Yan},
title = {Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study},
journal = {The British Journal of Radiology},
year = {2023},
doi = {10.1259/bjr.20221195}
}
EUVIMED